SLE serum induces altered goblet cell differentiation and leakiness in human intestinal organoids

Inga Viktoria Hensel(BioMed X Institute), Szabolcs Éliás(BioMed X Institute), Michelle Steinhauer(BioMed X Institute), Bilgenaz Stoll(BioMed X Institute), Salvatore Benfatto(BioMed X Institute), Wolfgang Merkt(Heidelberg University), Stefan Krienke(Heidelberg University), Hanns‐Martin Lorenz(Heidelberg University), Jürgen Haas(Heidelberg University), Brigitte Wildemann(Heidelberg University), Martín Resnik-Docampo(BioMed X Institute)
EMBO Molecular Medicine
February 5, 2024
Cited by 8Open Access
Full Text

Abstract

Human intestinal epithelial cells are the interface between luminal content and basally residing immune cells. They form a tight monolayer that constantly secretes mucus creating a multilayered protective barrier. Alterations in this barrier can lead to increased permeability which is common in systemic lupus erythematosus (SLE) patients. However, it remains unexplored how the barrier is affected. Here, we present an in vitro model specifically designed to examine the effects of SLE on epithelial cells. We utilize human colon organoids that are stimulated with serum from SLE patients. Combining transcriptomic with functional analyses revealed that SLE serum induced an expression profile marked by a reduction of goblet cell markers and changed mucus composition. In addition, organoids exhibited imbalanced cellular composition along with enhanced permeability, altered mitochondrial function, and an interferon gene signature. Similarly, transcriptomic analysis of SLE colon biopsies revealed a downregulation of secretory markers. Our work uncovers a crucial connection between SLE and intestinal homeostasis that might be promoted in vivo through the blood, offering insights into the causal connection of barrier dysfunction and autoimmune diseases.


Related Papers

No related papers found

Powered by citation graph analysis